Annual Quaterly

Annual

Quaterly

Operating Results Financial condition Cash Flows Per share data Major Indicators Segments Data Drug Fostering Program formulations "Growing"formulations Other

Operating Results Financial condition Cash Flows Segments Data Drug Fostering Program formulations "Growing"formulations Other

Other

*Japanese GAAP

(Unit：millions of yen)

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Investments※	9,638	6,455	11,912	9,085	6,304	11,161	12,095	14,679	21,908	31,077	37,489
Capital investments	9,638	6,455	11,912	9,085	6,304	11,161	11,456	11,172	18,352	28,650	35,349
R&D expenses	5,968	6,087	6,048	5,926	6,270	6,631	7,313	7,594	8,288	8,355	8,484
Depreciation	5,059	5,629	6,157	6,362	6,406	8,210	8,743	10,101	10,235	10,620	12,291

1.Financial year ends on the 31st March
2.From year ending 31 March 2023, the "acquisition of property, plant and equipment" has been changed to "investment amount of property, plant and equipment and software, etc."
*Investments in property, plant and equipment and software

provided by StockWeather.com,Inc.